Scarica l'app Stockscreener
1.92
3.23%
0.06
Dopo l'orario di chiusura:
1.96
0.04
+2.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CAMP Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.86
Aprire:
$1.89
Volume 24 ore:
47,625
Relative Volume:
0.18
Capitalizzazione di mercato:
$39.91M
Reddito:
$264.74M
Utile/perdita netta:
$-49.71M
Rapporto P/E:
-0.4688
EPS:
-4.0959
Flusso di cassa netto:
$-43.55M
1 W Prestazione:
-3.03%
1M Prestazione:
-17.24%
6M Prestazione:
-75.42%
1 anno Prestazione:
+117.19%
Intervallo 1D:
$1.87
$1.95
Intervallo di 1 settimana:
$1.84
$2.07
Portata 52W:
$0.3901
$12.30
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
Nome
Camp 4 Therapeutics Corp
Settore
Industria
Telefono
617-651-8867
Indirizzo
ONE KENDALL SQUARE, CAMBRIDGE, CA
Confronta CAMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAMP
Camp 4 Therapeutics Corp
|
1.92 | 39.91M | 264.74M | -49.71M | -43.55M | -4.0959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Iniziato | Wedbush | Outperform |
| 2024-11-05 | Iniziato | JP Morgan | Overweight |
| 2024-11-05 | Iniziato | Piper Sandler | Overweight |
| 2024-11-05 | Iniziato | William Blair | Outperform |
| 2022-08-16 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2021-12-22 | Downgrade | Craig Hallum | Buy → Hold |
| 2021-09-24 | Reiterato | Craig Hallum | Buy |
| 2021-06-25 | Reiterato | Craig Hallum | Buy |
| 2020-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-04-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-05 | Reiterato | Craig Hallum | Buy |
| 2019-12-20 | Reiterato | Craig Hallum | Buy |
| 2019-12-20 | Downgrade | First Analysis Sec | Outperform → Neutral |
| 2019-06-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2019-05-29 | Downgrade | Goldman | Neutral → Sell |
| 2019-05-01 | Reiterato | Craig Hallum | Buy |
| 2019-03-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-01-25 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-12-21 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2018-12-14 | Reiterato | B. Riley FBR | Buy |
| 2018-12-11 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2018-12-11 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2018-11-27 | Iniziato | Goldman | Neutral |
| 2018-10-15 | Iniziato | Jefferies | Hold |
| 2018-09-28 | Reiterato | Craig Hallum | Hold |
| 2018-04-27 | Reiterato | Craig Hallum | Hold |
| 2018-03-08 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-02-16 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
Mostra tutto
Camp 4 Therapeutics Corp Borsa (CAMP) Ultime notizie
CalAmp Corp. Announces CEO Changes, Effective January 22, 2024 - marketscreener.com
CalAmp Corp. Announces the Appointment of Paul Washicko as the New Senior Vice President of Product Management - marketscreener.com
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Wedbush sets CAMP4 stock at Outperform, $8 price target - Investing.com Australia
Wedbush sets CAMP4 stock at Outperform, $8 price target By Investing.com - Investing.com UK
Wedbush Initiates CAMP4 Therapeutics at Outperform With $8 Price Target - marketscreener.com
Parent's Night Out (6 months to 23 months) - Bucks County Herald newspaper
The Call EventsMount Saint Charles Middle School Field Hockey Clinic - woonsocketcall.com
ALT5 Sigma Corporation Announces Record Date for Alyea Therapeutics Corporation Transaction - The Joplin Globe
The Manufacturers Life Insurance Company Buys 3,095 Shares of Camping World Holdings, Inc. (NYSE:CWH) - Defense World
Therapeutic horseback riding facility hosts camp night for veterans, first responders - WSBT
CAMP4 Therapeutics Unveils Promising Data at ASGCT 2025 - TipRanks
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th - The Manila Times
CAMP4 Therapeutics Reports Positive Results in SYNGAP1-Related Disorders and Urea Cycle Disorders at ASGCT Annual Meeting - Nasdaq
CAMP4 Clinical Data Shows 50% Protein Boost in Primate Brain Study | CAMP Stock News - Stock Titan
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
CAMP4 Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating - TipRanks
CAMP4 Reports First Quarter 2025 Financial Results And Corporate Highlights - marketscreener.com
CAMP4 Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - Nasdaq
CAMP4 Clinical Trials Hit Major Milestone: Q1 Earnings Show Strong Pipeline Progress in Rare Disease Treatment - Stock Titan
Prediction: Nvidia Just Received Its First Wall Street Sell Rating -- and More Will Follow After May 28 - The Globe and Mail
Northeast Ohio Parent Camp and Summer Programs Guide 2025 - Northeast Ohio Parent
Jesse Dee - UnionLeader.com
Sranan Gold Announces Positive Engagement with the Local Community, a Major Stakeholder at the Tapanahony Project in Suriname - Yahoo Finance
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
14-year-old dies by suicide at Weaverville mental health program run by owner of shuttered Trails Carolina - Asheville Watchdog
Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.
Pre-market Movers: KTTA, SXTC, GLMD, TCMD... - RTTNews
New Ulcerative Colitis Drug PALI-2108 Outperforms Standard Treatments in Crucial Disease Models - Stock Titan
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Barrick Gold Trading Cheaper Than Industry: Time to Buy the Stock? - The Globe and Mail
Daily Times Chronicle EventsBoy Scout Troop 42 Pancake Breakfast - Homenewshere.com
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting - The Manila Times
CAMP4 Therapeutics to Present Preclinical and Phase 1 Clinical Trial Data at 28th Annual Meeting of the American Society of Gene and Cell Therapy - Nasdaq
Revolutionary RNA Therapy Shows Promise: CAMP4 Unveils First Human Trial Data at Gene Therapy Conference - Stock Titan
Global School of Chess Announces 100 Full-Scholarship Seats for New Inclusivity & Awareness Camp - Yahoo Finance
Home | Department of Parks and Recreation - City and County of Honolulu (.gov)
Machine Learning-Assisted Spectroscopy Ensures Safety of Cell Therapy | Research & Technology | Apr 2025 - Photonics Spectra
Where Will Rigetti Computing Be in 10 Years? - The Globe and Mail
Programmable Therapeutics Restore Gene Expression - Mirage News
Restoring healthy gene expression with programmable therapeutics - MIT News
10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer - The Globe and Mail
Explorer Finds Major Gold Structure in Ontario Camp - streetwisereports.com
Top 3 Health Care Stocks Poised for Big Gains in Q2 - NewsBreak: Local News & Alerts
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
‘We couldn’t do it without them’: Camp Able in need of volunteers for equine therapy - BigCountryHomepage.com
CalAmp : Quadro Vehicles S.A. Taps LoJack Italia for Advanced Connected Vehicle Technology and Security - MarketScreener
Manasa Pamboor holds free camp for physiotherapy, speech therapy and counseling - Daijiworld
Best Stock to Buy Right Now: Amazon vs. Home Depot - The Globe and Mail
Free Camp for Physiotherapy, Speech Therapy, and Counselling at Manasa Pamboor - Mangalorean.com
Camp 4 Therapeutics Corp Azioni (CAMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
1.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):